Similar articles

• Induction therapy with antithymocyte globulin reduces the incidence of allograft rejection and improves graft survival in cadaver renal transplantation.

  Abouna GM, Kumar MS, Stephan R, Prior JE, Lyons P, Bulova SI, al-Abdullah IH. Abouna GM, et al. Transplant Proc. 1993 Jun;25(3):2241-2. Transplant Proc. 1993. PMID: 8516886 No abstract available.
• Prophylactic OKT3, CyA, and steroids versus antilymphoblast globulin, CyA, and steroids in cadaveric kidney transplantation.

  Griñó JM, Castelao AM, Serón D, Gonzalez C, Galceran JM, Gil-Vernet S, Andrés E, Bover J, Torras J, Alsina J. Griñó JM, et al. Transplant Proc. 1992 Feb;24(1):39-41. Transplant Proc. 1992. PMID: 1539329 Clinical Trial. No abstract available.
• Impact of HLA matching, type of crossmatch, and immunosuppressive therapy on primary pediatric cadaver renal allograft survival.

  Kerman RH, Sullivan EK, Tejani A. Kerman RH, et al. Transplant Proc. 1995 Feb;27(1):656-7. Transplant Proc. 1995. PMID: 7879133 No abstract available.
• [Immunosuppressive therapy].

  Nakamura H. Nakamura H. Rinsho Byori. 1991 Jul;Suppl 90:102-14. Rinsho Byori. 1991. PMID: 1920848 Review. Japanese. No abstract available.
• Current clinical results of renal transplantation.

  Marchioro TL. Marchioro TL. Arch Intern Med. 1969 May;123(5):485-90. Arch Intern Med. 1969. PMID: 4888967 Review. No abstract available.